simultaneously negative in a small percentage of patients (<2-3%). The presence of both genetic markers is considered to be a necessary, but not sufficient condition for the diagnosis, as they also occur in up to 30% of the general non-celiac population.
The spectrum of duodenal histological changes in CD has expanded greatly since the inclusion of the new criteria introduced by Marsh in 1992 [8] . He successfully included celiac patients without villous atrophy, classifying them as type 1 when there was only an increased intraepithelial lymphocytosis (LIES) (>25% of LIES, per 100 epithelial cells). Type 2 is characterized by the presence of crypt hyperplasia without atrophy. Type 3, showing villous atrophy, is subdivided into three categories: mild (3a), moderate (3b) and intense (3c). Other classifications have since appeared, but they are basically very similar to the original Marsh classification [9, 10] .
The most important step towards achieving a diagnosis of CD is that every doctor looks for this entity and includes it in their differential process before a series of symptoms, and not only digestive but also long-term extra-intestinal usually. This is not achieved solely on the basis of clinical data and exploratory findings, but aided by analytical alterations, serological data, genetic markers and duodenal histopathological findings. If, after this process, reasonable doubts remain about its presence, it may be tentatively proposed that the patient follows a gluten-free diet (GFD) for at least six months, to assess their degree of response. Although a GFD is the only available and effective treatment, it should be made clear that it must be followed strictly and maintained for the rest of the patient's life, avoiding transgressions and contamination [11] .
Diagnosis is often delayed, the time following symptom onset being highly variable in adults, sometimes taking as long as 12 years. Barriers to accurate and timely diagnosis include atypical presentation, physicians' lack of awareness about current diagnostic criteria, misdiagnosis and general practitioners' limited access to specialists [12] . In a survey of 611 CD patients in Finland, 332 (54%) reported a delay in diagnosis of more than three years. This delay predisposed patients to reduced well-being and increased recourse to medicines and health care services, before the diagnosis and one year after diagnosis [13] . New guidelines have been issued for children who exhibit high serum TGT titers of more than ten times the normal value. In such cases it is not considered necessary to perform duodenal biopsies to confirm the diagnosis [14] .
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